Pre-Market Technical Scan on Chemicals Equities -- Celanese, ChromaDex, Rayonier Advanced Materials, and Sociedad Quimica y Minera de Chile

NEW YORK, April 18, 2018 /PRNewswire/ --

WallStEquities.com strives to bring the best free research to the investment community.  Today we are offering reports on CE, CDXC, RYAM, and SQM which can be accessed for free by signing up to www.wallstequities.com/registration. Today, WallStEquities.com observes the performance of Celanese Corp. (NYSE: CE), ChromaDex Corp. (NASDAQ: CDXC), Rayonier Advanced Materials Inc. (NYSE: RYAM), and Sociedad Quimica y Minera de Chile S.A. (NYSE: SQM). These stocks belong to the Major Diversified Chemicals industry, which is something of a general store to almost every other manufacturing company out there, supplying the basic building blocks of almost everything produced. All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Celanese

On Tuesday, shares in Irving, Texas headquartered Celanese Corp. recorded a trading volume of 1.83 million shares, which was above their three months average volume of 805,020 shares. The stock ended the session 3.72% higher at $110.38. The Company's shares have gained 3.42% in the last month, 0.65% over the previous three months, and 21.97% over the past year. The stock is trading 7.30% above its 50-day moving average and 7.01% above its 200-day moving average. Moreover, shares of Celanese, which manufactures and sells value-added chemicals, thermoplastic polymers, and other chemical-based products worldwide, have a Relative Strength Index (RSI) of 66.34.  

On April 17^th, 2018, Celanese reported its results for the three months ended March 31^st, 2018. GAAP diluted earnings per share (EPS) for Q1 2018 were $2.68, the Company's second highest ever. Adjusted EPS was a record $2.79. Net sales for the quarter expanded 26% year-over-year to $1.9 billion. Operating cash flow in the first quarter was $143 million, free cash flow was $55 million, and capital expenditures were $86 million. Get the full research report on CE for free by clicking below at: www.wallstequities.com/registration/?symbol=CE

ChromaDex

Irvine, California-based ChromaDex Corp.'s stock closed the day 6.03% lower at $4.05 with a total trading volume of 353,200 shares. The Company's shares have advanced 69.46% over the past year. The stock is trading 14.13% below its 200-day moving average. Additionally, shares of ChromaDex, which operates as a nutraceutical company, have an RSI of 40.66.  

On March 29^th, 2018, ChromaDex announced that results from a human clinical study of NIAGEN^®, a cutting-edge form of vitamin B3, led by Christopher Martens, PhD and Douglas Seals, PhD of the Integrative Physiology of Aging Laboratory at the University of Colorado, Boulder, were reported and published that day in the journal, Nature Communications. The results provide conclusive evidence that chronic nicotinamide riboside supplementation is effective at raising levels of nicotinamide adenine dinucleotide in humans, without adverse effects.  Free research on CDXC can be accessed at: www.wallstequities.com/registration/?symbol=CDXC

Rayonier Advanced Materials

Shares in Jacksonville, Florida headquartered Rayonier Advanced Materials Inc. recorded a trading volume of 1.06 million shares, which was higher than their three months average volume of 921,800 shares. The stock ended yesterday's trading session 5.09% higher at $22.31. The Company's shares have advanced 9.20% in the past month, 14.47% in the previous three months, and 74.43% over the past year. The stock is trading above its 50-day and 200-day moving averages by 11.87% and 30.74%, respectively. Furthermore, shares of the Company, which manufactures and sells cellulose specialty products in the US, China, Japan, Europe, Latin America, other Asian countries, Canada, and internationally, have an RSI of 64.73.  

On April 10^th, 2018, Rayonier Advanced Materials announced that its Board of Directors has declared a second quarter cash dividend of $2.00 per share of Mandatory Convertible Preferred Stock of the Company. The dividend is payable on May 15^th, 2018, to stockholders of record on May 01^st, 2018. Visit WallStEquities.com now and sign up for the free research on RYAM at: www.wallstequities.com/registration/?symbol=RYAM

Sociedad Quimica y Minera de Chile

Santiago, Chile headquartered Sociedad Quimica y Minera de Chile S.A.'s stock finished Tuesday's session 1.81% higher at $53.41 with a total trading volume of 839,192 shares. The Company's shares have advanced 9.76% in the last month and 47.54% over the past year. The stock is trading above its 50-day and 200-day moving averages by 4.17% and 2.98%, respectively. Additionally, shares of the Company, which produces and distributes specialty plant nutrients, industrial chemicals, iodine and derivatives, lithium and derivatives, potassium, and other products and services, have an RSI of 59.04. The free technical report on SQM is available at: www.wallstequities.com/registration/?symbol=SQM

--

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: [email protected]
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Wall St. Equities